These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6602555)

  • 1. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the renal tubular effects of vitamin D by cycloheximide in the rat.
    Brezis M; Wald H; Shilo R; Popovtzer MM
    Pflugers Arch; 1983 Aug; 398(3):247-52. PubMed ID: 6688870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine does not interfere with the antiphosphaturic effect of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Wald H; Kopolovic J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(2-3):103-9. PubMed ID: 2837627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxycholecalciferol and 1,25-dihydroxycholecalciferol enhances phosphaturia in rats with reduced renal mass: evidence for a PTH-dependent mechanism.
    Rubinger D; Wald H; Popovtzer MM
    Miner Electrolyte Metab; 1990; 16(6):348-54. PubMed ID: 1965220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo and in vitro effect of calmodulin antagonists on the renal actions of 25(OH) vitamin D3 in the rat.
    Friedlaender MM; Darmon D; Wald H; Popovtzer MM
    Pflugers Arch; 1989 Dec; 415(3):372-80. PubMed ID: 2560171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for interference of 25(OH)vitamin D3 with phosphaturic action of glucagon.
    Popovtzer MM; Wald H
    Am J Physiol; 1981 Apr; 240(4):F269-75. PubMed ID: 7223886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 25(OH)vitamin D3 on urinary excretion of cyclic adenosine monophosphate.
    Popovtzer MM; Robinette JB
    Am J Physiol; 1975 Oct; 229(4):907-10. PubMed ID: 171964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
    Marcus R; Orner FB; Brickman AS
    Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of some hydroxylated vitamin D metabolites on parathyrin secretion by dispersed rat parathyroid cells in vitro.
    Gruson M; Demignon J; Del Pino Montes J; Miravet L
    Steroids; 1982 Sep; 40(3):275-85. PubMed ID: 6985176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of active vitamin D preparations on PTH secretion in rats.
    Kugai N; Koide Y; Kimura S; Yamashita K
    Endocrinol Jpn; 1984 Apr; 31(2):151-8. PubMed ID: 6086295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal parathyroid hormone-dependent adenylate cyclase in vitamin D-deficient rats. Inhibition by hydroxylated vitamin D3 metabolites.
    Cloix JF; d'Herbigny E; Ulmann A
    J Biol Chem; 1980 Dec; 255(23):11280-3. PubMed ID: 6254964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
    Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
    Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxycholecalciferols modulate parathyroid hormone and calcitonin sensitive adenylyl cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3.
    Gordeladze JO; Gautvik KM
    Biochem Pharmacol; 1986 Mar; 35(6):899-902. PubMed ID: 3485429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism.
    Omdahl JL
    J Biol Chem; 1978 Dec; 253(23):8474-8. PubMed ID: 711762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.